Le Lézard
Classified in: Ebola virus, Health, Science and technology
Subject: PDT

GxAlert Adds HCV Data Transmission and Alert Capabilities



SPRINGFIELD, Mass. and JOHANNESBURG, Oct. 18, 2017 /PRNewswire/ -- SystemOne, the leader in global disease intelligence for rapid detection and response, recently announced that its GxAlert software is now configured to transmit HCV data for GeneXpert's® Xpert® HCV Viral Load assay. 71 million people were estimated to be infected with chronic HCV in 2015, and estimates point to the disease being responsible for 350,000 to 500,000 deaths per year. Unlike some other infectious diseases, for example HIV and TB, the number of deaths due to viral hepatitis is increasing over time.

Recent progress in treatment for HCV means that global health authorities are now able to discuss the possibility of eradicating HCV. "We believe eradication of any infectious disease can only happen when information moves more quickly than the disease," said Chris Macek, CEO, SystemOne. "Medical solutions are critical to saving lives, but they must be coupled with data solutions that enable clinical, logistical, global health and pharmaceutical stakeholders to know where and how to deploy resources and treatment. In HCV's case, earlier diagnosis is linked to better outcomes, and HCV is curable if the patient is linked to treatment."

GxAlert is now able to:

GxAlert currently works with numerous diseases in over 35 countries, and its users rely on over 40,000 medical diagnostic and system notifications each month.

Xpert HCV Viral Load is a quantitative test that provides on-demand molecular testing for diagnosis and monitoring of HCV. Based on the GeneXpert technology, Xpert HCV Viral Load utilizes automated reverse transcriptase polymerase chain reaction (RT-PCR) to provide a result within 105 minutes. GxAlert can now ensure that these results are automatically sent to healthcare providers to ensure prompt decision making.  

"GxAlert can provide accurate, real-time reporting and linkage to appropriate care to support global targets," said Natasha Gous, Medical Science Liaison, SystemOne. "In May 2016, at the World Health Assembly, 194 countries adopted the first-ever Global Health Sector Strategy on Viral Hepatitis, agreeing to eliminate hepatitis as a public health threat by 2030."

About SystemOne:
Founded in Massachusetts in 2012, SystemOne focuses on producing solutions for disease surveillance and response. SystemOne has offices in Springfield and Boston, MA and Johannesburg, South Africa.

The company's new disease intelligence software, Aspect®, addresses numerous infectious diseases including Zika, Ebola, HIV, Malaria, Hepatitis C and more on a host of diagnostic devices.

For more information please email us at: info@systemone.id.  

To connect with SystemOne on Twitter please visit:https://twitter.com/SystemOneCo 
To connect with SystemOne on Instagram please visit:https://www.instagram.com/systemoneco

SOURCE SystemOne


These press releases may also interest you

at 02:33
During the period 18 June 2018 to 21 June 2018, Karo Pharma AB (publ) (LEI code 213800G54Z51LOPGTA79) has repurchased in total 383 289 own shares (ISIN:  SE00007464888). The repurchases form part of the SEK 86.3 million share repurchase programme...

at 02:00
Based on its recent analysis of the global clinical laboratory automation market, Frost & Sullivan recognizes Inpeco with the 2018 Global Company of the Year Award for designing, implementing, and integrating world-class total laboratory automation...

at 01:35
On June 22nd in Hong Kong, Luye Pharma Group hosted a conference to unveil their Global Collaboration Strategy. Liu Dianbo, Chairman of Luye Pharma Group, said at the event, "Starting in 2019, Luye Pharma will gradually begin to enter into a period...

at 01:15
Nordic Nanovector ASA (OSE: NANO) announces that Eduardo Bravo has been appointed as its Chief Executive Officer. Mr. Bravo brings more than 25 years' experience in the biopharmaceutical industry and a strong track record in leading and growing...

at 00:00
HENDERSON, Nev., June 25, 2018 /PRNewswire-PRWeb/ --Thomas Valentine, a hospital corpsman, third class, who served aboard the USS Saratoga and has participated in Operation Desert Shield, has completed his new book "Screams Overboard": a stirring...

24 jun 2018
WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and Harbour BioMed, a global biopharmaceutical company developing...




News published on 18 october 2017 at 10:44 and distributed by: